| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/02/2012 | WO2012015972A1 Compositions and methods for inhibition of the jak pathway |
| 02/02/2012 | WO2012015775A2 Sirna targeting vegfa and methods for treatment in vivo |
| 02/02/2012 | WO2012015211A2 Opthalmic formulation containing cyclosporine a |
| 02/02/2012 | WO2012013884A1 Compounds for the treatment/prevention of ocular inflammatory diseases |
| 02/02/2012 | WO2012013736A1 Preservative-free composition for topical use including hyaluronic acid |
| 02/02/2012 | WO2012013249A1 Dentin matrix protein 1 (dmp1) for use in pharmaceutical compositions |
| 02/02/2012 | WO2012013111A1 Angiogenesis-inhibiting peptide and application thereof |
| 02/02/2012 | WO2012013110A1 Polypeptide having angiogenesis-inhibiting activity |
| 02/02/2012 | WO2011149354A8 Mirnas involved in the blood brain barrier function |
| 02/02/2012 | US20120029087 Use of rasagiline for the treatment of olfactory dysfunction |
| 02/02/2012 | US20120029084 Topical Nepafenac Formulations |
| 02/02/2012 | US20120029073 Pharmaceutical compositions having desirable bioavailability |
| 02/02/2012 | US20120029051 siRNA Targeting VEGFA and Methods for Treatment In Vivo |
| 02/02/2012 | US20120029029 Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta hsd1 modulators |
| 02/02/2012 | US20120029026 Pyridine derivative |
| 02/02/2012 | US20120029016 Indoles Useful in the Treatment of Inflammation |
| 02/02/2012 | US20120029007 Morphinan compounds |
| 02/02/2012 | US20120029005 Spiperone derivatives and methods of treating disorders |
| 02/02/2012 | US20120028994 Compounds for the reduction of beta-amyloid production |
| 02/02/2012 | US20120028970 Heteroarylthiomethyl pyridine derivative |
| 02/02/2012 | US20120028950 Substituted heterocyclylbenzylpyrazoles and use thereof |
| 02/02/2012 | US20120028947 Ophthalmic Compositions |
| 02/02/2012 | US20120028944 Cyclodextrin nanotechnology for ophthalmic drug delivery |
| 02/02/2012 | US20120028939 Substituted naphthyridines and their use as medicaments |
| 02/02/2012 | US20120028938 Pyrazole compounds as crth2 antagonists |
| 02/02/2012 | US20120028929 Tetracycline stabilizing formulations |
| 02/02/2012 | US20120028910 Storage-stable aqueous ophthalmic formulations |
| 02/02/2012 | US20120028896 Use of fibroblast growth factor fragments |
| 02/02/2012 | US20120028880 Vegfr-1/nrp-1 targeting peptides |
| 02/02/2012 | US20120027842 Topical formulations of flap inhibitors for administration to an eye |
| 02/02/2012 | US20120027812 Intraocular lenses treated with alkylphosphocholines for pharmacological aftercataract prophylaxis |
| 02/02/2012 | US20120027787 Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use |
| 02/02/2012 | US20120027774 Metalloproteinase 9 binding proteins |
| 02/02/2012 | US20120027744 Modified heparinase iii and methods of sequencing therewith |
| 02/02/2012 | US20120027723 Taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration |
| 02/02/2012 | US20120027716 Povidone Iodine, A Novel Alternative Preservative For Ophthalmic Compositions |
| 02/02/2012 | CA2806942A1 Compounds for the treatment/prevention of ocular inflammatory diseases |
| 02/02/2012 | CA2804199A1 Compositions and methods for inhibition of the jak pathway |
| 02/02/2012 | CA2803689A1 Method for treating ophthalmic diseases using kinase inhibitor compounds in prodrug forms |
| 02/01/2012 | EP2411052A2 Carrier comprising a vitamin e derivative |
| 02/01/2012 | EP2411013A1 Intraocular sustained release drug delivery systems and methods for treating ocular conditions |
| 02/01/2012 | EP1286989B1 Prodrug of an ICE inhibitor |
| 02/01/2012 | CN1951899B 阿司匹林触发的脂质介体 Aspirin-triggered lipid mediators |
| 02/01/2012 | CN102341400A Pyrrolopyrimidines used as kinase inhibitors |
| 02/01/2012 | CN102341386A Pyridine derivative |
| 02/01/2012 | CN102341385A Piperazine compound capable of inhibiting prostaglandin d synthase |
| 02/01/2012 | CN102341094A Cationic oil-in-water emulsions containing prostaglandins and uses thereof |
| 02/01/2012 | CN102341093A Anionic oil-in-water emulsions containing prostaglandins and uses thereof |
| 02/01/2012 | CN102336812A Polypeptide possessing angiogenesis inhibitory activity |
| 02/01/2012 | CN102336811A Novel small peptide capable of inhibiting new vessels and application thereof |
| 02/01/2012 | CN102336724A Novel cinepazide salt and its preparation method, and pharmaceutical composition based on cinepazide salt |
| 02/01/2012 | CN102336716A 嘧啶衍生物 Pyrimidine derivatives |
| 02/01/2012 | CN102335412A Health-care product for otitis media |
| 02/01/2012 | CN102335278A Chinese medicament for expelling wind, clearing away heat and treating conjunctivitis and preparation method thereof |
| 02/01/2012 | CN102335226A Extract of rust-coloured crotalaria herb with root for treating epicophosis and tinnitus, and preparation method and application thereof |
| 02/01/2012 | CN102335173A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 02/01/2012 | CN101979037B 一种治疗糖尿病并发症的药物及其制备方法 A drug and its preparation method of treatment of diabetic complications |
| 02/01/2012 | CN101972341B 通窍复音汤 Tongqiao polyphony soup |
| 02/01/2012 | CN101810772B 治疗突发性耳聋耳鸣的中药 Treatment of sudden deafness, tinnitus medicine |
| 02/01/2012 | CN101700317B 一种能改善眼底和视网膜微循环病变及修复眼部病变损伤的制剂及其制备方法 Can help improve retinal and retinal microcirculation lesions and repair damaged eye disease and its preparation method |
| 02/01/2012 | CN101337987B 一种用于抗白内障的靶蛋白 An anti-cataract target protein |
| 01/31/2012 | US8106218 Pharmaceutical compounds |
| 01/31/2012 | US8106063 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 01/31/2012 | US8105580 Methods of using adipose derived stem cells to promote wound healing |
| 01/26/2012 | WO2012012375A1 Composition for retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome using omega choline |
| 01/26/2012 | WO2012012184A2 Ophthalmic devices containing chemokine antagonists |
| 01/26/2012 | WO2012011591A1 Fused heterocyclic compound and application thereof |
| 01/26/2012 | WO2012011128A1 Preparation of prostaglandin derivatives |
| 01/26/2012 | WO2012010415A1 Pharmaceutical composition containing a tryptophan derivative |
| 01/26/2012 | WO2011106702A3 Sustained delivery of therapeutic agents to an eye compartment |
| 01/26/2012 | US20120022149 Pharmaceutical composition with enhanced solubility characteristics |
| 01/26/2012 | US20120022147 2, 6 xylidine derivatives for the treatment of pain |
| 01/26/2012 | US20120022138 Means for inhibiting the expression of ang2 |
| 01/26/2012 | US20120022137 METHOD OF CONTROLLING INITIAL DRUG RELEASE OF siRNA FROM SUSTAINED-RELEASE IMPLANTS |
| 01/26/2012 | US20120022100 Organic compounds |
| 01/26/2012 | US20120022092 Protein kinase c inhibitors and uses thereof |
| 01/26/2012 | US20120022080 Plasminogen Activator Inhibitor-1 Inhibitor |
| 01/26/2012 | US20120022077 Novel cyanopyrimidine derivative |
| 01/26/2012 | US20120022035 Polymorphic and Amorphous Salt Forms of Squalamine Dilactate |
| 01/26/2012 | US20120022034 Methods for reducing or neovascularization or edema |
| 01/26/2012 | US20120022030 Tetracyclic Lactame Derivatives |
| 01/26/2012 | US20120022013 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 01/26/2012 | US20120022002 SUSTAINED RELEASE siRNA FOR OCULAR DRUG DELIVERY |
| 01/26/2012 | US20120021987 Mucin 3 EGF-Like Domains |
| 01/26/2012 | US20120021974 Novel inhibitor of angiogenesis |
| 01/26/2012 | US20120021072 Compositions For The Treatment And Prevention Of Eyelid Swelling |
| 01/26/2012 | US20120021016 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 01/26/2012 | US20120021013 Composition Containing Sulfoalkyl Ether Cyclodextrin and Latanoprost |
| 01/26/2012 | US20120020979 METHODS FOR TREATING IgE-MEDIATED DISORDER |
| 01/26/2012 | US20120020956 Activation of sodium potassium atpase |
| 01/26/2012 | US20120020936 Treatment of neurodegenerative disease using placental stem cells |
| 01/26/2012 | US20120020916 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
| 01/26/2012 | US20120020889 Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 and Alpha V Beta 3 Integrin |
| 01/26/2012 | US20120020882 Peptide-based compounds |
| 01/26/2012 | CA2806258A1 Fused heterocyclic compound and application thereof |
| 01/26/2012 | CA2805968A1 Pharmaceutical composition containing a tryptophan derivative |
| 01/26/2012 | CA2805242A1 Bifunctional rho kinase inhibitor compounds, composition and use |
| 01/26/2012 | CA2803368A1 Ophthalmic devices containing chemokine antagonists |
| 01/25/2012 | EP2409687A1 Water insoluble polymer matrix for drug delivery |
| 01/25/2012 | EP2408446A1 Use of pharmaceutical compositions containing mesembrenone |